<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39441851</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7358</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS computational biology</Title><ISOAbbreviation>PLoS Comput Biol</ISOAbbreviation></Journal><ArticleTitle>Modelling the impact of vaccination on COVID-19 in African countries.</ArticleTitle><Pagination><StartPage>e1012456</StartPage><MedlinePgn>e1012456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pcbi.1012456</ELocationID><Abstract><AbstractText>The rapid development of vaccines to combat the spread of COVID-19, caused by the SARS-CoV-2 virus, is a great scientific achievement. Before the development of the COVID-19 vaccines, most studies capitalized on the available data that did not include pharmaceutical measures. Such studies focused on the impact of non-pharmaceutical measures such as social distancing, sanitation, use of face masks, and lockdowns to study the spread of COVID-19. In this study, we used the SIDARTHE-V model, an extension of the SIDARTHE model, which includes vaccination rollouts. We studied the impact of vaccination on the severity of the virus, specifically focusing on death rates, in African countries. The SIRDATHE-V model parameters were extracted by simultaneously fitting the COVID-19 cumulative data of deaths, recoveries, active cases, and full vaccinations reported by the governments of Ghana, Kenya, Mozambique, Nigeria, South Africa, Togo, and Zambia. Using South Africa as a case study, our analysis showed that the cumulative death rates declined drastically with the increased extent of vaccination drives. Whilst the infection rates sometimes increased with the arrival of new coronavirus variants, the death rates did not increase as they did before vaccination.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathebula</LastName><ForeName>Dephney</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9069-0708</Identifier><AffiliationInfo><Affiliation>Department of Decision Sciences, University of South Africa, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amankwah</LastName><ForeName>Abigail</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Cape Coast, Cape Coast, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amouzouvi</LastName><ForeName>Kossi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>ScaDS.AI Dresden/Leipzig, TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mathematics, KNUST, Kumasi, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assamagan</LastName><ForeName>Kétévi Adiklè</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Brookhaven National Laboratory, Physics Department, Upton, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azote</LastName><ForeName>Somiealo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physics, Syracuse University, Syracuse, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fajemisin</LastName><ForeName>Jesutofunmi Ayo</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Physics, University of South Florida, Tampa, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fankam Fankame</LastName><ForeName>Jean Baptiste</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Molecular Sciences Institute, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guga</LastName><ForeName>Aluwani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Cape, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamwela</LastName><ForeName>Moses</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Lusaka Apex Medical University, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanduza</LastName><ForeName>Mulape Mutule</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Cancer Diseases Hospital, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mabote</LastName><ForeName>Toivo Samuel</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Physics and Electronics, Rhodes University, Grahamstown, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macucule</LastName><ForeName>Francisco Fenias</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Department of Mathematical Sciences, University of South Africa, Florida, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muronga</LastName><ForeName>Azwinndini</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Science, Nelson Mandela University, Gqeberha, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Njeri</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Mathematics, Statistics and Physics, Newcastle University, Newcastle Upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oluwole</LastName><ForeName>Michael Olusegun</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Physics, University of Ibadan, Oyo, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulo</LastName><ForeName>Cláudio Moisés</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Physics, University Eduardo Mondlane, Maputo, Mozambique.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Comput Biol</MedlineTA><NlmUniqueID>101238922</NlmUniqueID><ISSNLinking>1553-734X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="Y">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39441851</ArticleId><ArticleId IdType="pmc">PMC11498717</ArticleId><ArticleId IdType="doi">10.1371/journal.pcbi.1012456</ArticleId><ArticleId IdType="pii">PCOMPBIOL-D-23-00324</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. Publisher: Elsevier. doi: 10.1016/j.ijantimicag.2020.105924</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105924</ArticleId><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al.. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–1987. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31142-9/fulltext?. Publisher: Elsevier. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263814</ArticleId><ArticleId IdType="pubmed">32497510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieneldien T, Kim J, Cao J, Cao C. COVID-19 vaccines: current conditions and future prospects. Biol. 2021;10(10):960. Publisher: MDPI. doi: 10.3390/biology10100960</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10100960</ArticleId><ArticleId IdType="pmc">PMC8533517</ArticleId><ArticleId IdType="pubmed">34681059</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kashte S, Gulbake A, El-Amin SF III, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021;34(3):711–733. https://link.springer.com/article/10.1007/s13577-021-00512-4 Publisher: Springer. 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-021-00512-4</ArticleId><ArticleId IdType="pmc">PMC7937046</ArticleId><ArticleId IdType="pubmed">33677814</ArticleId></ArticleIdList></Reference><Reference><Citation>Impouma B, Mboussou F, Farham B, Makubalo L, Mwinga K, Onyango A, et al.. COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward. Epidemiol Infect. 2022;150:e143. Publisher: Cambridge University Press. doi: 10.1017/S0950268822001212</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268822001212</ArticleId><ArticleId IdType="pmc">PMC9354475</ArticleId><ArticleId IdType="pubmed">35818789</ArticleId></ArticleIdList></Reference><Reference><Citation>
Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al.. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947–953. https://www.nature.com/articles/s41562-021-01122-8. Publisher: Nature Publishing Group UK London. 
</Citation><ArticleIdList><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>
Zbiri S, Boukhalfa C. Inequality in COVID-19 vaccination in Africa. Journal of Public Health in Africa. 2023;14(7). https://publichealthinafrica.org/index.php/jphia/article/view/156 Publisher: PAGEPress Publications. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10481897</ArticleId><ArticleId IdType="pubmed">37680874</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ning C, Wang H, Wu J, Chen Q, Pei H, Gao H. The COVID-19 vaccination and vaccine inequity worldwide: an empirical study based on global data. Int J Environ Res Public Health. 2022;19(9):5267. https://www.mdpi.com/1660-4601/19/9/5267. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9102773</ArticleId><ArticleId IdType="pubmed">35564661</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano G, Colaneri M, Di Filippo A, Blanchini F, Bolzern P, De Nicolao G, et al.. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy. Nature Medicine. 2021;27(6):993–998. Publisher: Nature Publishing Group. doi: 10.1038/s41591-021-01334-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01334-5</ArticleId><ArticleId IdType="pmc">PMC8205853</ArticleId><ArticleId IdType="pubmed">33864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Amouzouvi K, Assamagan KÁ, Azote S, Connell SH, Fankam JB, Fanomezana F, et al.. A model of COVID-19 pandemic evolution in African countries. Scientific African. 2021;14:e00987. doi: 10.1016/j.sciaf.2021.e00987</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sciaf.2021.e00987</ArticleId><ArticleId IdType="pmc">PMC8467372</ArticleId><ArticleId IdType="pubmed">34604610</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, et al.. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nature Medicine. 2020;26(6):855–860. Publisher: Nature Publishing Group. doi: 10.1038/s41591-020-0883-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0883-7</ArticleId><ArticleId IdType="pmc">PMC7175834</ArticleId><ArticleId IdType="pubmed">32322102</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Driessche P, Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci. 2002;180(1-2):29–48. doi: 10.1016/S0025-5564(02)00108-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-5564(02)00108-6</ArticleId><ArticleId IdType="pubmed">12387915</ArticleId></ArticleIdList></Reference><Reference><Citation>NCBI. Coronavirus outbreak in Nigeria: Burden and socio-medical response during the first 100 days. Available at: https://ncbi.nlm.nih.gov/pmc/articles/PMC7307993/. Accessed March 27, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307993</ArticleId><ArticleId IdType="pubmed">32585282</ArticleId></ArticleIdList></Reference><Reference><Citation>NCAA. Re-flight restriction into Nigeria due to COVID-19. Available at: http://ncaa.gov.ng/media-center/news/re-update-on-clarification-of-flight-restriction-into-nigeria-due-to-covid-19-pandemic/. Accessed March 27, 2022.</Citation></Reference><Reference><Citation>NCDC. COVID-19 Regulations 2020—NCDC. Available at: http://covid19.ncdc.gov.ng/media/archives/COVID-19_REGULATIONS_2020_20200330214102_kOhShx.pdf. Accessed March 27, 2022.</Citation></Reference><Reference><Citation>WHO Regional Office for Africa. Public health protocols on COVID-19. NCDC Coronavirus COVID-19 Microsite. Available at: http://covid19.ncdc.gov.ng/. Accessed March 27, 2022.</Citation></Reference><Reference><Citation>NCDC. Coronavirus Disease (COVID-19) Health Protection Regulations 2021. NCDC Coronavirus COVID-19 Microsite. Available at: https://covid19.ncdc.gov.ng/guideline/. Accessed March 27, 2022.</Citation></Reference><Reference><Citation>Vaccine Updates—SA Corona Virus Online Portal. Available at: https://sacoronavirus.co.za/vaccine-updates/. 2022.</Citation></Reference><Reference><Citation>Voice of Nigeria. Nigeria to receive over 41m doses of COVID-19 vaccines. Available at: https://von.gov.ng/nigeria-to-receive-over-41m-doses-of-COVID-19-vaccines-by-september/. Accessed March 20, 2022.</Citation></Reference><Reference><Citation>Sato R. Pattern of vaccination delivery around COVID-19 lockdown in Nigeria. Hum Vaccines Immunother. 2021;17(9):2951–2953. Publisher: Taylor &amp; Francis. doi: 10.1080/21645515.2021.1908061</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1908061</ArticleId><ArticleId IdType="pmc">PMC8381828</ArticleId><ArticleId IdType="pubmed">33945404</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Kenya. COVID-19 Press Release. 2020. Available from: https://www.health.go.ke/press-releases/.</Citation></Reference><Reference><Citation>
Orangi S, Pinchoff J, Mwanga D, Abuya T, Hamaluba M, Warimwe G, et al.. Assessing the level and determinants of COVID-19 vaccine confidence in Kenya. Vaccines. 2021;9(8):936. Available from: https://www.mdpi.com/2076-393X/9/8/936. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8402839</ArticleId><ArticleId IdType="pubmed">34452061</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Regional Office for Africa. COVID-19 vaccination in the WHO African Region—7 February 2022. Available from: https://www.afro.who.int/publications/covid-19-vaccination-who-african-region-7-february-2022. Accessed March 18, 2022.</Citation></Reference><Reference><Citation>Muchiri SK, Muthee R, Kiarie H, Sitienei J, Agweyu A, Atkinson PM, et al.. Unmet need for COVID-19 vaccination coverage in Kenya. Vaccine. 2022;40(13):2011–2019. doi: 10.1016/j.vaccine.2022.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.02.035</ArticleId><ArticleId IdType="pmc">PMC8841160</ArticleId><ArticleId IdType="pubmed">35184925</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamptey E, Serwaa D, Appiah AB. A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana. Clin Exp Vaccine Res. 2021;10(2):183. doi: 10.7774/cevr.2021.10.2.183</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2021.10.2.183</ArticleId><ArticleId IdType="pmc">PMC8217584</ArticleId><ArticleId IdType="pubmed">34222131</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonvignon J, Owusu R, Asare B, Adjagba A, Aun YW, Yeung KHT, et al.. Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool. Vaccine. 2022;40(12):1879–1887. doi: 10.1016/j.vaccine.2022.01.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.01.036</ArticleId><ArticleId IdType="pmc">PMC8813551</ArticleId><ArticleId IdType="pubmed">35190206</ArticleId></ArticleIdList></Reference><Reference><Citation>
Amponsah SK, Tagoe B, Afriyie DK. One year after first case of COVID-19 in Ghana: epidemiology, challenges and accomplishments. Pan Afr Med J. 2021;39(1). https://www.ajol.info/index.php/pamj/article/view/221919. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486924</ArticleId><ArticleId IdType="pubmed">34630838</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Regional Office for Africa. Ghana finds success in COVID-19 mass vaccination campaigns. Available from: https://www.afro.who.int/countries/ghana/news/ghana-finds-success-covid-19-mass-vaccination-campaigns#:~:text=The%20country%20aims%20to%20administer%202.3. Accessed May 18, 2022.</Citation></Reference><Reference><Citation>Arhinful E. Bawumia, Samira also receive COVID-19 vaccine. Available from: https://citinewsroom.com/2021/03/bawumia-samira-also-receive-covid-19-vaccine-photos/. Accessed March 1, 2021.</Citation></Reference><Reference><Citation>
Morang’a CM, Ngoi JM, Gyamfi J, Amuzu DSY, Nuertey BD, Soglo PM, et al.. Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021. Nat Commun. 2022;13(1):2494. https://www.nature.com/articles/s41467-022-30219-5. 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9076825</ArticleId><ArticleId IdType="pubmed">35523782</ArticleId></ArticleIdList></Reference><Reference><Citation>GHS COVID-19 Dashboard. GHS COVID-19 Situation Dashboard-Ghana. Available from: https://accugeospatial.com/index.php/covid-19-ghana-dashboard/. Accessed 2022.</Citation></Reference><Reference><Citation>Government of the Republic of Mozambique. Daily COVID-19 Surveillance Bulletin, Ministry of Health. 2020. Available from: https://covid19.ins.gov.mz/documentos-em-pdf/boletins-diarios/. Accessed March 3, 2022.</Citation></Reference><Reference><Citation>Government of the Republic of Mozambique. Press releases, Ministry of Health. 2020. Available from: https://covid19.ins.gov.mz/documentos-em-pdf/comunicacoes-diarias/. Accessed March 18, 2022.</Citation></Reference><Reference><Citation>Government of the Republic of Mozambique. Declaration of Public Calamity Situation, Council of Ministers, Maputo. 2021. Available from: https://www.mic.gov.mz/por/Legislacao-anexos/Decreto-n.1-7-2021-de-5-de-Marco. Accessed February 15, 2022.</Citation></Reference><Reference><Citation>Government of the Republic of Mozambique. Daily update of information about COVID-19, Ministry of Health. 2021. Available from: https://covid19.ins.gov.mz/wp-content/uploads/2021/03/Actualizacao-Dados-Covid-19_15.03.2021.pdf. Accessed April 10, 2022.</Citation></Reference><Reference><Citation>Government of the Republic of Mozambique. Daily update of information about COVID-19, Ministry of Health. 2022. Available from: https://covid19.ins.gov.mz/wp-content/uploads/2022/01/Comunicado-de-Imprensa-COVID-19-23.01.2022-VF.pdf. Accessed March 23, 2022.</Citation></Reference><Reference><Citation>World Health Organization. COVID-19 national deployment and vaccination plan: submission and review process, 29 January 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-NDVP-country_plans-2021.1. 2021.</Citation></Reference><Reference><Citation>Konu YR, Gbeasor-Komlanvi FA, Yerima M, Sadio A, Tchankoni MK, Zida-Compaore WIC, et al. Prevalence of severe adverse events in health professionals after receiving the first dose of the COVID-19 vaccination in Togo, March 2021. medRxiv. 2021. Available at: https://www.medrxiv.org/content/early/2021/04/20/2021.04.20.21254863. Publisher: Cold Spring Harbor Laboratory Press.</Citation></Reference><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/. 2021–2022.</Citation></Reference><Reference><Citation>World Health Organization. Togo vaccinates over 90% of health workers against COVID-19. Available at: https://www.afro.who.int/news/togo-vaccinates-over-90-health-workers-against-covid-19. 2021.</Citation></Reference><Reference><Citation>Gittings L, Casale M, Kannemeyer N, Rayalo N, Cluver L, Kelly J, et al.. Even if I’m well informed, I will never get it”: COVID-19 vaccine beliefs, intentions and acceptability among adolescents and young people in South Africa. S Afr Health Rev. 2021;2021(1):297–304.</Citation></Reference><Reference><Citation>Alemayehu A, Yusuf M, Demissie A, Abdullahi Y. Determinants of COVID-19 vaccine uptake and barriers to being vaccinated among first-round eligibles for COVID-19 vaccination in Eastern Ethiopia: A community-based cross-sectional study. SAGE Open Med. 2022;10:20503121221077585. doi: 10.1177/20503121221077585</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121221077585</ArticleId><ArticleId IdType="pmc">PMC8832626</ArticleId><ArticleId IdType="pubmed">35154745</ArticleId></ArticleIdList></Reference><Reference><Citation>Adunimay AW, Ojo TA. Western centric medicine for COVID-19 and its contradictions: can African alternate solutions be the cure? Front Polit Sci. 2022;4:835238. doi: 10.3389/fpos.2022.835238</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpos.2022.835238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health, Zambia. Ministerial statement on COVID-19 and the acquisition of vaccines for COVID-19 by the Hon. Minister of Health (Dr Chanda), MP. Available at: https://www.parliament.gov.zm/sites/default/files/images/publication_docs/Ministerial%20Statement%20-%20On%20Covid-19%20and%20the%20acquisition%20of%20Vaccines%20%2007.04.21.pdf. 2021.</Citation></Reference><Reference><Citation>World Health Organization. Zambia receives 4,500,000 doses of COVID-19 vaccines from Canada. Available at: https://www.afro.who.int/countries/zambia/news/zambia-receives-4500000-doses-covid-19-vaccines-canada#:~:text=Zambia%20has%20received%2014.9%20million,been%20brought%20into%20the%20country. 2022.</Citation></Reference><Reference><Citation>UNICEF. COVID-19 vaccines shipped by COVAX arrive in Zambia—donation by France. Available at: https://www.unicef.org/zambia/press-releases/covid-19-vaccines-shipped-covax-arrive-zambia-donation-france. 2022.</Citation></Reference><Reference><Citation>Zambia National Public Health Institute. Zambia COVID-19 Situation Report NO. 366—EPI Week 21. Available at: http://znphi.co.zm/wpcontent/uploads/2022/06/Zambia_COVID-Weekly-Situational-Report-No-366_Week-ending-29May2022_Final.pdf. 2022.</Citation></Reference><Reference><Citation>The South African Government. COVID-19 Coronavirus vaccine. Available at: https://www.gov.za/covid-19/vaccine/vaccine#. 2022.</Citation></Reference><Reference><Citation>South African Government. About alert system. Available at: https://www.gov.za/covid-19/about/about-alert-system. 2022.</Citation></Reference><Reference><Citation>National Institute for Communicable Diseases. Latest confirmed cases of COVID-19 in South Africa (9 June 2022). Available at: https://www.nicd.ac.za/latest-confirmed-cases-of-covid-19-in-south-africa-9-june-2022/. 2022.</Citation></Reference><Reference><Citation>Peter J, Day C, Takuva S, Takalani A, Engelbrecht I, Garrett N, et al.. Allergic reactions to the Ad26.COV2.S vaccine in South Africa. J Allergy Clin Immunol Global. 2022;1(1):2–8. doi: 10.1016/j.jacig.2021.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacig.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC10509997</ArticleId><ArticleId IdType="pubmed">37780073</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisonke (Together): OPEN LABEL TRIAL. Available at: https://sisonkestudy.samrc.ac.za/SisonkeProtocol.pdf. 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>